News articles about PetIQ (NASDAQ:PETQ) have trended somewhat positive this week, Accern reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. PetIQ earned a news impact score of 0.16 on Accern’s scale. Accern also gave news articles about the company an impact score of 45.1680344701983 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
These are some of the news articles that may have effected Accern Sentiment’s scoring:
A number of analysts have recently issued reports on the stock. Jefferies Group increased their price target on shares of PetIQ from $25.00 to $26.00 and gave the stock a “hold” rating in a research report on Tuesday, November 7th. Zacks Investment Research lowered shares of PetIQ from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 12th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $26.83.
PetIQ (PETQ) traded down $0.20 during midday trading on Wednesday, hitting $23.30. 282,600 shares of the stock were exchanged, compared to its average volume of 326,800. The company has a quick ratio of 4.67, a current ratio of 6.83 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $504.60 and a price-to-earnings ratio of -86.30. PetIQ has a 1-year low of $17.03 and a 1-year high of $28.23.
PetIQ (NASDAQ:PETQ) last released its quarterly earnings data on Monday, November 6th. The company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.15. equities research analysts predict that PetIQ will post 0.76 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “PetIQ (PETQ) Earns News Impact Rating of 0.16” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/17/petiq-petq-earns-news-impact-rating-of-0-16.html.
PetIQ Company Profile
PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.